Challenges and Opportunities for Clinical Trials in Patients With Glioma

JAMA Neurol. 2023 Mar 1;80(3):227-228. doi: 10.1001/jamaneurol.2022.4924.

Authors

L Nicolas Gonzalez Castro^{1

2}, Isabel C Arrillaga-Romany³, Tracy T Batchelor^{2

1}

Affiliations

¹ Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
² Department of Neurology, Brigham and Women's Hospital, Boston, Massachusetts.
³ Neuro-Oncology, Mass General Cancer Center, Boston, Massachusetts.

PMID: 36648934
DOI: 10.1001/jamaneurol.2022.4924

No abstract available

Plain language summary

This Viewpoint discusses the challenges and opportunities of including patients with glioma in clinical trials.

MeSH terms

Brain Neoplasms* / therapy
Clinical Trials as Topic
Glioma* / therapy
Humans